2 unknown, 1 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Terminated 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Neuroendocrine: new trials by email Literature Review of Neuroendocrine trials Research Report on Neuroendocrine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors 68Ga-DOTATATE will be given in tracer doses and injected intravenously to image tumors by Positron Emission Tomography. - Neuroendocrine, Neuroendocrine Tumor | Phase 1 / Phase 2 | Unknown | Ochsner Health System | 250 | 2014-03-01 | 2014-01-17 |
| Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers JI-101, Everolimus - Cancer, Neuroendocrine | Phase 1 / Phase 2 | Terminated | University of Utah | 19 | 2010-09-01 | 2014-10-06 |
| Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features Seneca Valley Virus (biological agent) - Carcinoid, Neuroendocrine | Phase 1 | Unknown | Neotropix | 60 | 2006-04-01 | 2010-02-25 |
Carcinoid Tumor (2) · Adenoma, Islet Cell (1) · Apudoma (1) · Carcinoma, Neuroendocrine (1) · Colonic Neoplasms (1) · Glioblastoma (1) · Medulloblastoma (1) · Neoplasms (1) · Neuroblastoma (1) · Neuroendocrine Tumors (1) · Ovarian Neoplasms (1) · Retinoblastoma (1) · Rhabdomyosarcoma (1) · Rhabdomyosarcoma, Alveolar (1) · Sarcoma, Ewing (1)
Neoplasms by Site (3) · Adenocarcinoma (2) · Carcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2)
1-(1-(2-amino-pyridin-4-ylmethyl)-1H-indol-4-yl)-3-(5-bromo-2-methoxyphenyl)urea (1) · Biological Factors (1) · Everolimus (1)
Neotropix (1) · Ochsner Health System (1) · University of Utah (1)
United States (3)
Rudin Charles, MD, PhD (1) · Sunil Sharma, MD (1)